Sorrento wraps up $150M placement to advance pipeline, partnering plans | Fierce Biotech
12 titoli sanitari in movimento, sessione regolare del 21/02/2023 - Benzinga Italia
SCLX - Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce the Closing of their Previously Announced Business Combination
Sorrento Therapeutics crolla dopo ricorso al Chapter 11
Perché oggi le azioni di Sorrento Therapeutics sono aumentate
Sorrento Therapeutics crolla dopo ricorso al Chapter 11
Finché in Borsa dura il gioco del cerino godiamocelo tutto - ilGiornale.it
SCLX - Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce the Closing of their Previously Announced Business Combination
Azioni Sorrento Therapeutics: Quotazione e Analisi | Emanuele Perini